Intelliseq

🌟 Meet with Our Team at #AMPath2024! 🌟 We’re excited to connect with you on Day 3 of the Association for Molecular Pathology (AMP) Conference! Stop by Booth #521 to learn about our cutting-edge iFlow platform in molecular diagnostics and comprehensive data analysis. Don’t miss this opportunity to see our solutions in action and discuss how we can support your goals. See you soon! #AMPath2024 #GeneSpect #iFlow #Innovation #DataAnalysis #Teamwork

🎉 Thank You for Joining Our Corporate Workshop! A huge thank you to everyone who attended our recent corporate workshop! During the workshop, we delved into tools designed for comprehensive genetic data analysis, showcasing how they can drive insights from population-level trends to individual genetic profiles. We extend our thanks to our business partner, DNAnexus, for the invitation and the opportunity to conduct this workshop together. We are excited about strengthening our partnership and exploring future opportunities to advance innovation in genetic data analysis, together! Curious to learn more about Cohort Browser and GeneSpect Reporters available on DNAnexus Platform? 🌟 We’d love to share how these tools can support your projects and goals. #Genomics #DataInnovation #CohortBrowser #GeneSpectReporters #PersonalizedMedicine #AdvancedCancerResearch #ThankYou #Workshop

Join us tomorrow at the Association for Molecular Pathology (AMP) 2024 Innovation Spotlight! 🚀 In this presentation, Klaudia Pacewicz, Product Manager at Intelliseq, and Marzena Wojtaszewska, PhD, Head of the Molecular Biology Laboratory, University Hospital in Rzeszow, will showcase the cutting-edge capabilities of our iFlow platform for tertiary analysis of NGS data. Don't miss this exciting opportunity to see how iFlow can transform your workflows with automated, accurate, and efficient data interpretation! 👇 🖊 Title: GeneSpect™ Reports: Automated NGS Data Interpretation 🗓️ Date: Thursday, November 21 🕒 Time: 3:45 – 4:15 PM 📍 Location: Stage #1 We look forward to seeing you there!

Are you going to the Association for Molecular Pathology (AMP) 2024 Annual Expo? If so, we'd love to have you join this exciting presentation with our partner Intelliseq. Save your spot here: https://hubs.ly/Q02W0H9Y0

Join DNAnexus and us at Association for Molecular Pathology (AMP) 2024 for a Corporate Workshop! In this presentation, we will showcase our latest advances in comprehensive genomic tools that can support your research, from population-level to individual insights, enabling physicians and researchers to gain a deeper understanding of cancer genetics and beyond. Don't miss this opportunity!👇 🖊 Title: Unlocking Cancer Insights: Advanced Tertiary Analysis with DNAnexus and Intelliseq 🗓️ Date: Wednesday, November 20 🕒 Time: 3:00 - 3:50 PM 📍Location: 202 - 204, Level 2 #cancergenetics #precisionmedicine #clinicalinsights #DNAnexus #Intelliseq #populationresearch

We’re excited to announce that we’ll be at the Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo in Vancouver, BC! From November 19 to November 23, our team will be on-site, ready to connect, showcase our innovations, and dive into the latest developments in pathology and molecular diagnostics! 💼 Stop by our booth #521 to meet our team and learn how we’re working to advance automatic genetic data analysis and interpretation. Let’s discuss how we can drive impactful solutions together. 📅 Don't miss our presentations on Corporate Workshop Day, November 20, and Innovative Spotlights, November 21. If you’re attending, don’t hesitate to reach out—let’s make AMP 2024 a memorable and productive experience. Here’s to new connections, inspiration, and transformative breakthroughs! #AMP2024 #Vancouver #MolecularPathology #PrecisionMedicine #GenomicTesting #Innovation

❓ Is a heterozygous variant of high pathogenicity with a reported recessive inheritance pattern sufficient to cause disease? ❓ What is the difference in predicting the likelihood of disease development when two pathogenic variants within a single gene are present on the same allele versus different alleles? What is compound heterozygosity? ✅ Learn how to resolve these complexities and how easy it is to obtain this information with the GeneSpect Hereditary Reporter → https://lnkd.in/gTff8DVV 

Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS) genomic analyses can be used to address a wide range of questions 🧬Applications can range from preventive screening for pathogenic variants to the identification of variants associated with rare diseases or cancer. Given the large amount of data involved, it is essential to define the scope of the analysis accurately to ensure that it addresses the specific clinical question. A critical step in this process is the creation of a customized panel of genes to be analyzed. It is essential to identify which genes or variants may be associated with specific conditions. This process may involve screening databases, scientific literature, and expert guidelines. Fortunately, you don't have to do this manually and all by yourself, find out the link to the full article in the comments section down below 👇

Discover how optimizing phasing in genotyping can improve PGx workflows. Our latest article reveals how accurate haplotype determination with advanced tools like Intelliseq Polygenic boosts precision in drug response predictions, ensuring optimal treatment plans🌟 🔗 Read the full article: https://lnkd.in/eM6cth34 #Pharmacogenomics #PersonalizedMedicine #Genotyping #Phasing

We were delighted to showcase our innovative solutions dedicated to pharmacogenetics and polygenic risk score analysis and reporting at BioMeeting 2024, where we had the opportunity to engage with industry leaders, young researchers, and professionals. The posters focused on solutions within the genomic data processing workflows integrated into our two cutting-edge products: the GeneSpect PGx Reporter and the GeneSpect PRS Reporter. Read more and view full posters here: https://lnkd.in/dw3bxAS3